Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Nectar Lifesciences Ltd. ( (IN:NECLIFE) ) is now available.
Nectar Lifesciences Ltd. has entered into a Business Transfer Agreement with Capnest Health Care Private Limited to sell its Empty Hard Gelatin Capsule manufacturing, distribution and marketing unit located at Bhatoli Kalan, Baddi, Himachal Pradesh, on a slump sale and going-concern basis. The transaction, valued at INR 19.9 crore along with the takeover of related receivables, payables and other working capital adjustments, involves a business that contributed 1.28% of the company’s FY25 revenue and 2.25% of its net worth, and is expected to close on or before April 30, 2026; the buyer is unrelated to the promoter group, indicating a non-related-party divestment of a relatively small unit as the company fine-tunes its portfolio and capital allocation.
More about Nectar Lifesciences Ltd.
Nectar Lifesciences Ltd. is an Indian pharmaceutical company engaged in manufacturing and marketing healthcare products, including active pharmaceutical ingredients and finished dosage forms, with operations spread across multiple facilities in northern India.
Average Trading Volume: 247,676
Technical Sentiment Signal: Hold
Current Market Cap: 4.89B INR
Learn more about NECLIFE stock on TipRanks’ Stock Analysis page.